Skip to Content

Aztreonam

In the US, Aztreonam (aztreonam systemic) is a member of the drug class miscellaneous antibiotics and is used to treat Bacteremia, Bacterial Infection, Bone infection, Cystic Fibrosis, Febrile Neutropenia, Intraabdominal Infection, Kidney Infections, Pelvic Inflammatory Disease, Peritonitis, Pneumonia, Pneumonia with Cystic Fibrosis, Skin and Structure Infection, Skin or Soft Tissue Infection and Urinary Tract Infection.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J01DF01

CAS registry number (Chemical Abstracts Service)

0078110-38-0

Chemical Formula

C13-H17-N5-O8-S2

Molecular Weight

435

Therapeutic Category

Antibacterial: Monobactam

Chemical Name

(Z)-2-[[[(2-amino-4-tiazolyl)[[(2S,3S)-2-metyl-4-oxo-1-sulfo-3-azetidinyl]carbamoyl]metylene]amino]oxy]-2-metylpropionic acid (WHO)

Foreign Names

  • Aztreonamum (Latin)
  • Aztreonam (German)
  • Aztréonam (French)
  • Aztreonam (Spanish)

Generic Names

  • Aztreonam (OS: DCIT, USAN, BAN, JAN)
  • Aztréonam (OS: DCF)
  • BRN 3577211 (IS)
  • SQ 26776 (IS: Squibb)
  • UNII-G2B4VE5GH8 (IS)
  • Aztreonam (PH: JP XVI, USP 37)
  • Aztreonam Lysine (OS: USAN)
  • Corus1020 (IS)
  • UNII-XNM7LT65NP (IS)

Brand Names

  • Atreon
    Square, Bangladesh
  • Azactam
    Abeefe Bristol-Myers Squibb, Peru; Bristol Myers Squibb, Spain; Bristol-Myers Squibb, Austria; Bristol-Myers Squibb, Australia; Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, Switzerland; Bristol-Myers Squibb, China; Bristol-Myers Squibb, Colombia; Bristol-Myers Squibb, Ecuador; Bristol-Myers Squibb, Greece; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, India; Bristol-Myers Squibb, Norway; Bristol-Myers Squibb, New Zealand; Bristol-Myers Squibb, Oman; Bristol-Myers Squibb, Pakistan; Bristol-Myers Squibb, Portugal; Bristol-Myers Squibb, Taiwan; Bristol-Myers Squibb, United States; Bristol-Myers Squibb, Venezuela; Bristol-Myers Squibb, South Africa; E.R. Squibb & Sons, United Kingdom; Eisai, Japan; Eurofarma, Brazil; Glaxo Smithkline, Lebanon; GlaxoSmithKline, Egypt
  • Aztram
    Shanxi C & Y, Philippines
  • Aztreo
    Zydus Cadila, India
  • Aztreonam
    Vitalis, Venezuela
  • Aztreonam Farmalogica
    Farmalogica, Colombia
  • Aztreonam Norgreen
    Norgreen, Argentina
  • Aztreonam Richet
    Richet, Argentina
  • Aztreonam Venus
    Venus Remedies, Colombia
  • Aztreonam Vitalis
    Vitalis, Colombia; Vitalis, Guatemala; Vitalis, Nicaragua
  • Cayston
    Gilead, Australia; Gilead, Canada; Gilead, Germany; Gilead, Greece; Gilead, Israel; Gilead, Lithuania; Gilead, Netherlands; Gilead, Slovakia; Gilead, United States
  • Primbactam
    Menarini, Italy
  • Trezam
    Glenmark, India
  • Vebac
    Fahrenheit, Indonesia
  • Cayston
    Gilead, Belgium; Gilead, Switzerland; Gilead, Denmark; Gilead, Spain; Gilead, Norway; Gilead, Portugal; Gilead, Sweden

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide